CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
Revenue | ||||
Commissions and fees | $ 2,014,000 | $ 2,603,000 | $ 4,116,000 | $ 4,903,000 |
Interest, marketing and distribution fees | 6,869,000 | 7,835,000 | 13,814,000 | 16,598,000 |
Principal transactions and proprietary trading | (3,771,000) | 3,574,000 | 9,190,000 | 7,080,000 |
Market making | 497,000 | 437,000 | 1,049,000 | 1,109,000 |
Stock borrow / stock loan | 7,522,000 | 4,696,000 | 12,359,000 | 8,794,000 |
Advisory fees | 791,000 | 551,000 | 1,539,000 | 1,041,000 |
Other income | 952,000 | 1,167,000 | 1,726,000 | 1,794,000 |
Total Revenue | 14,874,000 | 20,863,000 | 43,793,000 | 41,319,000 |
Expenses | ||||
Employee compensation and benefits | 13,388,000 | 10,307,000 | 25,310,000 | 20,683,000 |
Clearing fees, including execution costs | 448,000 | 238,000 | 902,000 | 666,000 |
Technology and communications | 1,045,000 | 880,000 | 2,150,000 | 1,756,000 |
Other general and administrative | 1,840,000 | 1,070,000 | 3,349,000 | 2,099,000 |
Data processing | 1,147,000 | 732,000 | 2,096,000 | 1,483,000 |
Rent and occupancy | 442,000 | 378,000 | 909,000 | 875,000 |
Professional fees | 1,451,000 | 1,240,000 | 2,810,000 | 2,277,000 |
Depreciation and amortization | 629,000 | 336,000 | 1,044,000 | 591,000 |
Interest expense | 98,000 | 60,000 | 187,000 | 111,000 |
Advertising and promotion | 218,000 | 43,000 | 372,000 | 97,000 |
Total Expenses | 20,706,000 | 15,284,000 | 39,129,000 | 30,638,000 |
Operating income (loss) | (5,832,000) | 5,579,000 | 4,664,000 | 10,681,000 |
Income (loss) before provision for income taxes | (5,832,000) | 5,579,000 | 4,664,000 | 10,681,000 |
Provision for (benefit from) income taxes | (1,113,000) | 1,532,000 | 722,000 | 2,947,000 |
Net income (loss) | (4,719,000) | 4,047,000 | 3,942,000 | 7,734,000 |
Less net income (loss) attributable to noncontrolling interests | 7,000 | (3,000) | 6,000 | |
Net income (loss) available to common stockholders | $ (4,719,000) | $ 4,040,000 | $ 3,945,000 | $ 7,728,000 |
Net income (loss) available to common stockholders per share of common stock | ||||
Basic (in Dollars per share) | $ (0.12) | $ 0.1 | $ 0.1 | $ 0.19 |
Diluted (in Dollars per share) | $ (0.12) | $ 0.1 | $ 0.1 | $ 0.19 |
Weighted average shares outstanding | ||||
Basic (in Shares) | 40,399,958 | 39,890,606 | 40,296,571 | 39,830,002 |
Diluted (in Shares) | 40,399,958 | 39,890,606 | 40,296,571 | 39,830,002 |
X | ||||||||||
- Definition Advertising and promotion. No definition available.
|
X | ||||||||||
- Definition Advisory fees revenue. No definition available.
|
X | ||||||||||
- Definition Market making income. No definition available.
|
X | ||||||||||
- Definition Revenue from commissions and fees. No definition available.
|
X | ||||||||||
- Definition Revenue from margin interest, marketing and distribution fees. No definition available.
|
X | ||||||||||
- Definition Stock borrow / stock loan income. No definition available.
|
X | ||||||||||
- Definition The amount of expense in the period for communications and data processing expense. No definition available.
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount of expenses incurred in the period for information technology and data processing products and services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of interest expense classified as operating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Portion of net income (loss) attributable to nonredeemable noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) resulting from the difference between acquisition price and selling price or fair value of trading assets and trading liabilities, and from the firm's direct investment activity, conducted separately from customer trading activities, including, but not limited to, investments in private equity, alternative investment products, real estate, and exchanges and memberships. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|